DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,176,161 | -0.6% | 45,047 | -3.8% | 0.45% | +5.7% |
Q2 2023 | $11,243,520 | -19.5% | 46,848 | -15.5% | 0.42% | -11.1% |
Q1 2023 | $13,973,854 | +110356.5% | 55,443 | +16.3% | 0.48% | +24.0% |
Q4 2022 | $12,651 | -99.9% | 47,664 | -28.1% | 0.38% | -30.8% |
Q3 2022 | $17,125,000 | +3.6% | 66,302 | +1.7% | 0.56% | +9.0% |
Q2 2022 | $16,535,000 | -11.1% | 65,223 | +2.9% | 0.51% | +5.2% |
Q1 2022 | $18,594,000 | -16.7% | 63,391 | -6.5% | 0.48% | -6.0% |
Q4 2021 | $22,315,000 | +17.1% | 67,824 | +8.3% | 0.52% | -1.9% |
Q3 2021 | $19,063,000 | +1.3% | 62,616 | -10.7% | 0.52% | +12.2% |
Q2 2021 | $18,814,000 | +16.7% | 70,107 | -2.1% | 0.47% | +10.6% |
Q1 2021 | $16,116,000 | -1.8% | 71,600 | -3.1% | 0.42% | -3.9% |
Q4 2020 | $16,411,000 | +15.5% | 73,878 | +12.0% | 0.44% | -8.9% |
Q3 2020 | $14,207,000 | +17.6% | 65,976 | -3.4% | 0.48% | +12.1% |
Q2 2020 | $12,079,000 | +24.6% | 68,310 | -2.5% | 0.43% | +29.4% |
Q1 2020 | $9,692,000 | -13.9% | 70,027 | -4.5% | 0.33% | +15.6% |
Q4 2019 | $11,260,000 | -5.0% | 73,364 | -10.6% | 0.29% | -13.8% |
Q3 2019 | $11,854,000 | -5.1% | 82,075 | -6.1% | 0.33% | -4.0% |
Q2 2019 | $12,492,000 | +22.8% | 87,404 | +13.4% | 0.35% | +20.0% |
Q1 2019 | $10,176,000 | -18.4% | 77,079 | -36.3% | 0.29% | -25.1% |
Q4 2018 | $12,469,000 | -6.1% | 120,916 | -1.0% | 0.39% | -2.0% |
Q3 2018 | $13,274,000 | +9.2% | 122,157 | -0.8% | 0.40% | +5.1% |
Q2 2018 | $12,153,000 | +4.9% | 123,153 | +4.0% | 0.38% | +62.8% |
Q1 2018 | $11,590,000 | -2.4% | 118,373 | -7.5% | 0.23% | +5.0% |
Q4 2017 | $11,872,000 | +0.7% | 127,906 | -7.0% | 0.22% | -0.9% |
Q3 2017 | $11,795,000 | +0.7% | 137,503 | -0.9% | 0.22% | -1.3% |
Q2 2017 | $11,708,000 | -6.1% | 138,737 | -4.8% | 0.22% | -3.8% |
Q1 2017 | $12,469,000 | +3.9% | 145,782 | -5.4% | 0.23% | +4.0% |
Q4 2016 | $12,000,000 | -0.2% | 154,161 | +0.5% | 0.22% | -6.2% |
Q3 2016 | $12,024,000 | -20.8% | 153,390 | +2.1% | 0.24% | -25.2% |
Q2 2016 | $15,173,000 | +4.4% | 150,230 | -2.0% | 0.32% | +4.9% |
Q1 2016 | $14,540,000 | +5.4% | 153,277 | +3.2% | 0.31% | +4.1% |
Q4 2015 | $13,798,000 | +7.0% | 148,555 | -1.8% | 0.29% | +3.5% |
Q3 2015 | $12,890,000 | -3.4% | 151,274 | -3.0% | 0.28% | +4.8% |
Q2 2015 | $13,343,000 | +2.6% | 155,900 | +1.8% | 0.27% | +6.3% |
Q1 2015 | $13,002,000 | -3.2% | 153,150 | -2.3% | 0.26% | -2.7% |
Q4 2014 | $13,434,000 | +10.6% | 156,742 | -1.9% | 0.26% | +1.2% |
Q3 2014 | $12,141,000 | -5.1% | 159,788 | -1.6% | 0.26% | -3.0% |
Q2 2014 | $12,791,000 | +4.0% | 162,468 | -0.9% | 0.27% | +3.1% |
Q1 2014 | $12,301,000 | -5.6% | 164,011 | -2.9% | 0.26% | -4.8% |
Q4 2013 | $13,035,000 | +5.0% | 168,850 | -5.7% | 0.27% | +1.1% |
Q3 2013 | $12,410,000 | +8.2% | 179,025 | -1.2% | 0.27% | +5.9% |
Q2 2013 | $11,467,000 | – | 181,159 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
MIROVA | 128,368 | $16,947,000 | 9.18% |
Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |